The role of surgery in stage IIIA non-small cell lung cancer

Hematology/Oncology Clinics of North America

Volumn 19, Issue 2, 2005, Pages 303-319

  Eberhardt, Wilfried E E ^a   Hepp, Rodrigo ^b   Stamatis, Georgios ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HOSPITAL PADRE HURTADO   (Chile)

^c RUHRLANDKLINIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; MITOMYCIN C; NAVELBINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARDIOTOXICITY; CLINICAL TRIAL; DECISION MAKING; FOLLOW UP; HUMAN; LEARNING; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MORBIDITY; MORTALITY; NORTH AMERICA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STANDARDIZATION; SURVIVAL;

EID: 17044416862     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2005.02.002     Document Type: Review

References (51)

1. F. Levi, F. Lucchini, and E. Negri Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960 Int J Cancer 110 2004 155 169
2. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 1 2004 8 29
3. R.J. Ginsberg, E.E. Vokes, and A. Raben Non-small cell lung cancer V.T. DeVita Jr S. Hellman S.A. Rosenberg Cancer: principles and practice of oncology 5th edition 1997 Lippincott Philadelphia 858 911
4. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
5. D.H. Johnson, A.T. Turrisi, and H.J. Pass Combined modality treatment for locally advanced non-small cell lung cancer H.J. Pass J. Mitchell D.H. Johnson Lung cancer: principles and practice 1996 Lippincott-Raven Philadelphia 863 873
6. International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
7. M.A. Socinski, D.E. Morris, and J.S. Halle Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial J Clin Oncol 22 2004 4341 4350
8. W. Eberhardt, T. Gauler, and R. Hepp The role of chemoradiotherapy in the treatment of stage III non small cell lung cancer Ann Oncol 15 Suppl 4 2004 71 80
9. F. Andre, D. Grunenwald, and J.P. Pignon Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications J Clin Oncol 18 2000 2981 2989
10. J. Vansteenkiste, B.M. Fischer, and C. Dooms Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review Lancet Oncol 5 2004 531 540
11. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 1995 899 909
12. G.V. Scagliotti, R. Fossati, and V. Torri Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
13. N. Martini, M.G. Kris, and B.J. Flehinger Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1373
14. A. Depierre, B. Millerron, and D. Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
15. T.L. Winton, R. Livingston, and D. Johnson A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non-small-cell lung cancer (NSCLC) Intergroup JBR.10 [abstract] Proc Am Soc Clin Oncol 40 2004
16. G.M. Strauss, J. Herndon, and M.A. Maddaus Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633 [abstract] Proc Am Soc Clin Oncol 40 2004
17. D. Grunenwald, and T. LeChevalier Stage category of non-small cell lung cancer: a new proposal J Natl Cancer Inst 89 1997 88 89
18. P.L. Weiden, and S. Piantadosi Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer. A phase 2 study of the LCSG Chest 106 1994 S344 S347
19. R. Rosell, J. Gomez-Codina, and C. Camps Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
20. J.A. Roth, E.N. Atkinson, and F. Fossella Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
21. H.I. Pass, H.W. Pogrebniak, and S.M. Steinberg Randomized trial of neoadjuvant therapy for lung cancer: interim analysis Ann Thorac Surg 53 6 1992 992 998
22. M. Van Kooten, M. Rosenberg, and M. Orlando Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer Invest New Drugs 20 2002 439 446
23. K.V. Mattson, R.P. Abratt, and G. ten Velde Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study Ann Oncol 14 2003 116 122
24. K. Nagai, R. Tsuchiya, and T. Mori A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J Thorac Cardiovasc Surg 125 2003 254 260
25. D.C. Betticher, S.F. Hsu Schmitz, and M. Totsch Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
26. S. Cigolari, C. Curcio, and A. Maiorino Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Res 23 2003 1803 1809
27. M.E. O'Brien, T. Splinter, and E.F. Smit Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. An EORTC phase II study (EORTC 08958) Eur J Cancer 39 2003 1416 1422
28. F. Cappuzzo, F. De Marinis, and F. Nelli Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small-cell lung cancer Lung Cancer 42 2003 355 361
29. F. Cappuzzo, G. Selvaggi, and V. Gregorc Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable stage IIIA-bulky N2 and stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study Cancer 98 2003 128 134
30. N. Lorent, P. De Leyn, and Y. Lievens Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience Ann Oncol 15 2004 1645 1653
31. P. Van Schil, J.P. Van Meerbeeck, and G. Kramer Surgery after induction chemotherapy: morbidity in the first 100 patients of the surgery arm of EORTC 08941 trial [abstract] Lung Cancer 41 2003 S45
32. K.S. Albain, V.W. Rusch, and J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
33. N.C. Choi, R.W. Carey, and W. Daly Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer J Clin Oncol 15 1997 712 722
34. W. Eberhardt, H. Wilke, and G. Stamatis Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial J Clin Oncol 16 1998 622 634
35. D.W. Johnstone, R.W. Byhardt, and D. Ettinger Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 54 2002 365 369
36. J. Pisch, T. Moskovitz, and O. Esik Concurrent paclitaxel-cisplatin and twice-a-day irradiation in stage IIIA and IIIB NSCLC shows improvement in local control and survival with acceptable hematologic toxicity Pathol Oncol Res 8 2002 163 169
37. A. Kuten, Y. Anacak, and R. Abdah-Bortnyak Neoadjuvant radiotherapy concurrent with weekly paclitaxel and carboplatin and followed by surgery in locally advanced non-small-cell lung cancer Am J Clin Oncol 26 2003 184 187
38. D. De Candis, S.C. Stani, and P. Bidoli Induction chemotherapy with carboplatin/paclitaxel followed by surgery or standard radiotherapy and concurrent daily low-dose cisplatin for locally advanced non-small cell lung cancer (NSCLC) Am J Clin Oncol 26 2003 265 269
39. M.M. DeCamp, T.W. Rice, and D.J. Adelstein Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer J Thorac Cardiovasc Surg 126 2003 17 27
40. L. Trodella, P. Granone, and S. Valente Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging Ann Oncol 15 2004 389 398
41. M. Machtay, J.H. Lee, and J.P. Stevenson Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long term results and associations with pathologic response J Thorac Cardiovasc Surg 127 1 2004 108 113
42. T. Gauler, W. Eberhardt, and C. Le Pechoux Multicenter German/French phase-II trial of induction-CTX followed by concurrent CTX/RTX +/- surgery in locally far advanced inoperable non-small-cell lung cancer stages IIIA(N2) and IIIB-mature results of a novel induction CTX regimen [abstract] J Cancer Res Clin Oncol 130 2004 S72
43. G. Friedel, W. Budach, and W. Spengler Phase-II trial on neo-adjuvant chemoradiation with paclitaxel/carboplatin in stage III NSCLC J Cancer Res Clin Oncol 130 2004 S72
44. K.S. Albain, C.B. Scott, and V.R. Rusch Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer: initial results from Intergroup Trial 0139 (RTOG 93-09) [abstract] Proc Am Soc Clin Oncol 22 2003 621
45. K.S. Albain, J.J. Crowley, and A.T. Turrisi III Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019 J Clin Oncol 20 2002 3454 3460
46. K.S. Albain, C.B. Scott, and V. Rusch Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus (CT/RT) induction followed by surgical resection for stage IIIA (pN2) non-small-cell lung cancer: first outcome analysis of north American Intergroup Trial 0139 (RTOG 93-09) [abstract] Lung Cancer 41 2003 S4
47. M. Thomas, H.N. Macha, and M. Ukena Cisplatin/etoposide (PE) followed by twice-daily chemoradiation (hfRT/CT) versus PE alone before surgery in stage III non-small-cell lung cancer (NSCLC): a randomized phase III trial of the German Lung Cancer Cooperative Group (GLCCG) [abstract] Proc Am Soc Clin Oncol 22 2004
48. D.R. Gandara, H. West, and K.S. Albain Defining the role of radiation therapy in combination with preoperative chemotherapy in stage III non-small cell lung cancer: rationale and design of a new intergroup study M.C. Perry American Society of Clinical Oncology: educational book 2004 2004 American Society of Clinical Oncology New Orleans (LA) 458 462
49. G. Stamatis, D. Djuric, and W.E. Eberhardt Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients Eur J Cardiothorac Surg 22 2002 292 297
50. W. Eberhardt, S. Korfee, and C. Pöttgen Operable stage IIIA NSCLC: prospectively randomized multicenter German trial of surgery and postoperative radiotherapy versus "trimodality treatment"-analysis of surgical results and toxicity [abstract] J Cancer Res Clin Oncol 130 2004 S72
51. M. Stuschke, W. Eberhardt, and C. Pottgen Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects J Clin Oncol 17 1999 2700 2709